Skip to main content

Poor Health Outcomes of Older Cancer Patients in the UK: Is Age Discrimination at Play?

Age discrimination can have many negative effects on the livelihoods of older people. Among these effects are poor health outcomes in older Britons suffering from cancer, according to a recent report from the King’s Fund, a health think tank, and Cancer Research UK.

In 2004-2005, England was spending close to £4 billion on cancer care, its 4th largest health expenditure among 24 health conditions. Although England’s healthcare spending is similar to other European countries, its health outcomes are worse in older adults with cancer. The report titled “How to improve cancer survival: Explaining England’s relatively poor rates,” looks at why poor health outcomes exist among cancer patients.

The report shows that cancer survival rates in England are worse than in other countries due to late diagnosis, delayed treatment, and under-treatment in the older patient population. Age is considered an influential factor in delaying cancer diagnosis, and older cancer patients reportedly receive less evaluation by cancer specialists. When they do, they are oftentimes offered fewer treatment options as a result of “age bias”.

Is age bias reflective of the values system in England and of the National Health System, and thus, is it responsible for the disproportionate rate of deaths due to cancer among older persons? Perhaps it is not age bias alone driving the poor health outcomes of older cancer patients, but maybe patients are choosing not to receive screening and non-standard treatments and clinicians are choosing not to offer these healthcare options due to the high rate of comorbidities and low life expectancies within this patient population.

The salient issue here is not whether older patients are receiving cancer screenings and treatment offered their younger counterparts, but whether they may actually benefit from these procedures. Would a frail 78-year-old woman with urinary incontinence and moderate cognitive impairment benefit from a mammography? Is age a discriminating factor associated with preventable deaths among older cancer patients?

The answers to these questions vary, depending on the source. The literature on benefits and burdens of cancer screening and treatment in older persons is contradictory at best. Below is a sampling of a handful of studies presenting diverse perspectives on the issue:



  • A 2001 U.S. retrospective observational study showed that among 216 older women (mean age of 81 years) receiving mammographies, only 2 (0.9%) may have benefited from the screening. 42% experienced pain or psychological distress as a result of the mammographies.

  • A 2007 systematic review by researchers in Switzerland suggests that older cancer patients with breast or gynecologic cancers are often undertreated, the effect of which is decreased prognosis. Age and comorbidities were found to be determining factors for undertreatment in older patients, with reportedly few studies actually focusing on the health effects of undertreatment.

  • A 2007 literature review from Italy looking at the correlation between colonoscopy and life expectancy found that although the rate of colorectal polyps detection in patients 80 and older was higher (29%) than the 50-54 (14%) and 74-79 (27%) age groups, life expectancy gain was smaller in the oldest age group (one and a half months compared to 10 months in the youngest age group).

  • A 2008 observational study from Spain found that among older patients with non-small cell lung cancer co-morbid conditions was more important than age in influencing treatment options.

    After reading these articles and several others of similar topic, the resounding bottom line seems to be that it is more important to focus on individualized geriatrics care than to generally promote screenings and non-standard treatments for older cancer patients.

    Findings from the King’s Fund cancer report will serve to galvanize the British government to improve geriatrics care, especially as it pertains to cancer screening and treatment for older persons. However, the question remains, will these efforts to endorse cancer screening and treatment among older persons outweigh the negative effects in practice?


By: Julie N. Thai [GeriPal International Correspondent]

Comments

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Elderhood: Podcast with Louise Aronson

In this week's podcast we talk with Louise Aronson MD, MFA, Professor of Geriatrics at UCSF about her new book Elderhood, available for purchase now for delivery on the release date June 11th.

We are one of the first to interview Louise, as she has interviews scheduled with other lesser media outlets to follow (CBS This Morning and Fresh Air with Terry...somebody).

This book is tremendously rich, covering a history of aging/geriatrics, Louise's own journey as a geriatrician facing burnout, aging and death of family of Louise's members, insightful stories of patients, and more.

We focus therefore on the 3 main things we think our listeners and readers will be interested in.

First - why the word "Elder" and "Elderhood" when JAGS/AGS and others recently decided that the preferred terminology was "older adult"?

Second - Robert Butler coined the term ageism in 1969 - where do we see ageism in contemporary writing/thinking?  We focus on Louise's…

Psychedelics: Podcast with Ira Byock

In this week's podcast, we talk with Dr. Ira Byock, a leading palliative care physician, author, and public advocate for improving care through the end of life.

Ira Byock wrote a provocative and compelling paper in the Journal of Pain and Symptom Management titled, "Taking Psychedelics Seriously."

In this podcast we challenge Ira Byock about the use of psychedelics for patients with serious and life-limiting illness.   Guest host Josh Biddle (UCSF Palliative care fellow) asks, "Should clinicians who prescribe psychedelics try them first to understand what their patient's are going through?" The answer is "yes" -- read or listen on for more!

While you're reading, I'll just go over and lick this toad.

-@AlexSmithMD





You can also find us on Youtube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher
Transcript
Eric: Welcome to the GeriPal Podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: Alex, I spy someone in our …